CVRx's Barostim therapy for heart failure symptoms receives new CPT Category I codes approved by AMA. This development will enhance reimbursement processes and expand patient access, with implementation set for January 1, 2026.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing